期刊文献+

靶向同源盒A10特异性干扰性小RNA序列的筛选及功能鉴定 被引量:1

Screening and verification of the siRNA targeted for the HOXA10 gene
原文传递
导出
摘要 目的筛选有效干扰同源盒(HOX)A10基因表达的特异性干扰性小RNA(siRNA)序列并鉴定其功能,为利用RNA干扰技术靶向HOXA10防治肿瘤提供实验依据。方法设计合成3对针对HOXA10基因不同位点的siRNA序列,应用阳离子脂质体介导转染人肺腺癌A549细胞,采用反转录-聚合酶链反应(RT—PCR)检测HOXA10 mRNA表达,以HOXA10与β-actin灰度比值(ODR)表示相对表达水平。筛选出抑制HOXA10效果最佳的siRNA序列,应用四甲基偶氮唑盐(MTT)和流式细胞术分别检测该siRNA干扰HOXA10后对A549细胞增殖和凋亡的影响。结果3对siRNA均能抑制HOXA10的表达,其中siRNA1抑制HOXA10 mRNA的表达最为明显,ODR为(20.190±1.698)%;siRNA1对A549细胞的增殖抑制率可达(69.793±2.092)%;siRNA转染后细胞凋亡率显著提高,siRNA1诱导A549凋亡作用最为明显,凋亡率为(29.593±2.670)%。结论筛选出的siRNA1序列可有效沉默HOXA10基因的表达,并能有效抑制A549细胞增殖、促进其凋亡。 Objective To obtain effective siRNA fragment of HOXA10 gene and verify its function,to supply experimental evidence for tumor prevention and curation by RNAi targeting to HOXA10 gene.Methods Three pairs of small interfering RNA targeting to the different sites of HOXA10 were designed and introduced into A549. The mRNA expression of HOXA10 of A549 was detected by semi-quantitative RT-PCR, the cell proliferation was assayed by MTT, the apoptosis was measured by flow cytometry. ' The most effective siRNA assay was screened and was tested the relationship between it and proliferation and apoptosis. Results The mRNA of HOXA10 was inhibited by three siRNAs in A549 ceils, among which siRNA1 gave the strongest inhibiting of HOXA10 by ODR was (20.190±1.698) %. The inhibitory rate of cell proliferation was (69.793±2.092) % and the apoptosis rate was (29.593±2.670) %. Conclusion siRNA1 can specifically degrade HOXA10 mRNA and inhibit the proliferation of A549 cell and promote its apoptosis.
出处 《肿瘤研究与临床》 CAS 2011年第11期743-746,共4页 Cancer Research and Clinic
基金 基金项目:山东省自然科学基金(Y2007C018)
关键词 肿瘤 基因 同源盒 RNA干扰 A549细胞 Neoplasms Genes, homeobox RNA interference A549 cell
  • 相关文献

参考文献8

  • 1Samuel S, Naora H. Homeobox gene expression in cancer: insights from developmental regulation and deregulation. Eur J Cancer, 2005, 4 i : 2428-2437.
  • 2Calvo R, West J, Franklin W, et al. Altered HOX and WNT7A expression in human lung cancer. Proe Natl Acad Sci U S A, 2000, 97: 12776-12781.
  • 3Olivieri D, Sykora MM, Sachidanandam R, el al. An in vivo RNAi assay identifies major genetic and cellular requirements for primary piRNA biogenesis in Drosophila. EMBO J, 2010, 29:3301-3317.
  • 4Thorsteinsdottir U, Sauvageau G, Hough MR, et al. Overexpression of HOXA10 in routine hematopoietic cells perturbs both myeloid and lymphoid differentiation and leads to acute myeloid leukemia. Mol Cell Biol, 1997, 17: 495-505.
  • 5Yasui W, Oue N, Sentani K, et al. Transcriptome dissection of gastric cancer: identification of novel diagnostic and therapeutic targets from pathology specimens. Pathol Int, 2009, 59: 121-136.
  • 6Griimn D, KayM A. Therapeutic application of RNAi is mRNA targeting finally ready for prime time? J Clin Invest, 2007, 117: 3633- 3641.
  • 7Harborth J, Elhashir SM, Vandenburgh K, et aL Sequence, chemical, and structural varialion of small interfering RNAs and short hairpin RNAs and the effect on mammalian gene silencing. Antisense Nucleic Acid Drug Dev, 2003, 13: 83-105.
  • 8Wang H, Lu Y, Huang W, et al. HoxA10 activates transcription of the gene encoding mitogen-aetivated protein kinase phosphatase 2(Mkp2) in myeloid ceils. J Biol Chem, 2007, 282: 16164-16176.

同被引文献11

  • 1费嘉,张洹.VEGF反义核酸与柔红霉素联用对增加髓性白血病细胞化疗敏感性的研究[J].肿瘤防治研究,2004,31(6):326-329. 被引量:6
  • 2Cwynarski K, Roberts IA, lacobelli S, et al. Stem cell trans plantation for chronic myeloid leukemia in children[J]. Blood, 2003,102(4) :1224-31.
  • 3Olivieri D, Sykora MM, Sachidanandam R, et al. An in vivo RNAi assay identifies major genetic and cellular requirements for primary piRNA biogenesis in Drosophila [J]. EMBO J, 2010,29(19) :3301-17.
  • 4Calvo R,West J,Franklin W,et al. Altered HOX and WNT7A expression in human lung cancer[J]. Proc Natl Acad Sci U S A,2000,97(23) :12776-81.
  • 5Bjornsson JM, Andersson E, Lundstrom P, et al. Proliferation of primitive myeloid progenitors can be reversibly induced by Hoxa10[J]. Blood,2001,98(12) :3301-8.
  • 6Rao MK, Maiti S, Ananthaswamy HN, et al. A highly active homeobox gene promoter regulated by Ets and Sp1 family members in normal granulosa cells and diverse tumor cell types[J]. J Biol Chem,2002,277(29) :26036-45.
  • 7Grimm D, Kay MA. Therapeutic application of RNAi is mRNA targeting finally ready for prime time? [J]. J Clin Invest,2007, 117(12) :3633-41.
  • 8Paddison PJ ,Caudy AA,Bernstein E,et al. Short hairpin RNAs (shRNAs) induce sequence-specific silencing in mammalian cells[J]. Genes Dev, 2002,16 (8) : 948-58.
  • 9Wu YH,You Y,Chen ZC,et al. Reversal of drug resistance by silencing Survivin gene expression in acute myeloid leukemia cells[J]. Acta Bioehim Pol,2008,55(4):673-811.
  • 10Wang H,Lu Y, Huang W,et al. HoxA10 activates transcription of the gene encoding mitogen activated protein kinase phosphatase 2(Mkp2)in myeloid cells[J].J Biol Chem,2007, 282(22):16164-76.

引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部